This month, we asked our readers whether it is true or false that Alcoholics Anonymous (AA) is a medically recognized treatment for alcoholism. By a narrow majority, most respondents knew the right answer. Do you?
As the debate over the Better Care Reconciliation Act continues, there has been a pivotal turn in many politicians’ perspectives on health care – even those who previously opposed Obamacare. There may be one reason to explain this shift: the opioid epidemic. There are many pressing issues concerning health care, including increased costs. But the opioid epidemic, which some experts believe may kill over 90,000 Americans a year in the near future, is by far the most significant.
Dr. Foote, Co-Founder and Executive Director at the Center for Motivation and Change (CMC) in New York, spoke during our Addiction Speaker Series about the organization’s national peer-to-peer parent coaching network for treatment of substance use, compulsive behavior disorders and trauma. We had the pleasure of interviewing Dr. Foote about CMC’s work.
As many people across the U.S. continue to struggle with opioid addiction, several lifesaving medicines remain out of reach because of their cost or availability. In 2010, the U.S. Food and Drug Administration approved Vivitrol – a once-per-month injection that blocks the effects of opioids and reduces cravings. Vivitrol is an injectable form of the medication naltrexone, which is taken orally several times per week, and has been used to treat opioid addiction for over 20 years.
As rates of opioid addiction and overdose continue to climb, public officials are grappling with effective ways of responding to this public health problem. One strategy for preventing opioid overdose deaths is through the use of naloxone, a medication that blocks the effects of opioids.
Why is it so hard for those living with addiction to find easy access to the care they need? This blog identifies four of the most common barriers to treatment and offers ways to overcome these challenges.
A relatively unknown prescribed opioid called Opana has hit hard in rural America, particularly in Indiana, and its misuse is reigniting concerns about a new HIV outbreak. This outbreak not only sheds light on the troubling opioid epidemic in the state, but also challenges the misconception that HIV is strictly an urban disease.
It’s that time of the year again when many resolve to quit smoking. A growing number of smoking cessation apps for smart phones are out on the market. But are there any good ones?
The past year has paved the way for governors throughout the northeast to step up and address the growing problems related to the availability of substance abuse treatment for their constituents. CASAColumbia applauds the serious attention devoted by these and other state officials for acknowledging our serious addiction problem and highlighting harm reduction and treatment, rather than incarceration, as the solution.
A research team at CASAColumbia was recently awarded funding by the Patient-Centered Outcomes Research Institute (PCORI), to study the most effective ways to enhance healthcare outcomes among adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and related behavioral problems, including substance use. The Buzz sat down with the project's principal investigator, Aaron Hogue, Ph.D., Director of Adolescent and Family Research, to discuss the new grant and learn more about why this research is so critically important.
Newsletter Additional Information
Thank you for subscribing
This information will be used to better customize your experience and help inform future tools and features on our website.